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Abstract Five unrelated patients are described with the clinical and electrical features of eyelid myoclonia with absences (EMA). In this syndrome brief, typical absences occur with rapid eyelid myoclonia associated with retropulsive movements of the eyeballs and occasionally of the head. The seizures are of shorter duration than in childhood absence epilepsy, and are accompanied by less profound impairment of consciousness. The electroencephalogram demonstrates high amplitude discharges consisting of spikes, multiple spikes and slow waves at a fluctuating frequency of 3-5 Hz and following eye closure, which disappear in darkness. Photosensitivity is also seen. Onset is in early childhood and EMA appears to persist into adult life. Treatment is sodium valproate in combination with either ethosuximide or a benzodiazepine. On and were associated with jerks of the eyelids and upward rotation of the eyeballs. The patient's past medical history was unremarkable and there was no family history of epilepsy. Neurological examination was normal; EEGwas not performed. Between the ages of 6 and 30 years the patient had six generalised tonic-clonic seizures. At 31 years of age EEG performed after partial sleep deprivation revealed the following: within seconds of awakening, there were frequent, generalised discharges of spike and multiple spike and slow waves at 3-4 Hz, lasting for between 3 and 5 s, but occasionally for up to 7-10 s ( fig 5) . During the discharges the patient opened her eyes with eyelid and eye brow myoclonus. There was also a slight backward jerk of the head, and an occasional jerk of the eyeballs. The patient stopped counting during the discharges. Most of the discharges occurred during eye closure but they also occurred when the eyes were closed but not in the dark. There was marked photosensitivity. The patient has never experienced any limb myoclonus. Treatment with ethosuximide reduced but did not abolish the absences; the addition of carbamazepine was associated with a deterioration. The patient has become virtually seizure-free on a combination of ethosuximide and sodium valproate.
The patient is currently aged 32 years, married, and a successful sales manager. Only patient 4 experienced frequent generalised tonic-clonic seizures, and this probably reflected initially inappropriate anti-epileptic medication. Although there is very little information on the long term prognosis in EMA, there is clear evidence (patients 4 and 5 and also a personal communication of Dr JBP Stephenson, Glasgow) that the condition persists into at least the third decade with no obvious detrimental effect on intellectual function.
Binnie and Jeavons' consider EMA to be a type of photosensitive epilepsy, but make the important point that EMA must be differentiated from self-induced seizures."' Our patients did not admit to self-inducing the seizures over many years of follow-up (either spontaneously or on direct questioning) and self-induction was not demonstrated following repeated and prolonged video-EEG recordings. The eyelid myoclonia never preceded the epileptiform discharges and the abnormal electrical discharges were not seen in the dark-for example, fig 4, patien-t 4 . Finally, the patients were of average or above average intelligence with no psychosocial or psychiatric problems, in contrast to a previous report," and all our patients expressed obvious relief when seizure control was achieved.
This syndrome has not hitherto been recognised by the International League Against Epilepsy. Our observations and those of others,'89 indicate that EMA should be classified as a specific epilepsy syndrome within the idiopathic generalised epilepsies.
